IsoRay Inc

IsoRay, Inc. (ISR) Stock Climbs On Lung Cancer Data

­ IsoRay, Inc. (NYSE MKT:ISR) IsoRay is a clinical stage biopharmaceutical company with a strong focus on treatment of cancer who’s stock is …

CNA Finance CNA Finance — May 21, 2015, 7:47 AM EDT

Company Update (NYSE MKT:ISR): Isoray, Inc.’s Cesium-131 Lung Cancer Treatment Reports 96% Success in Local Control and 100% Survival at 5 Years in High Risk Patients

IsoRay, Inc. (NYSE MKT:ISR), a medical technology company and innovator in seed brachytherapy and medical radioisotope applications, announced the on-line publication of the …

Corey Williams — May 20, 2015, 11:26 AM EDT

Company Update (NYSE MKT:ISR): Isoray, Inc. Reports Third Quarter Results

IsoRay, Inc. (NYSE MKT:ISR), a medical technology company and innovator in seed brachytherapy and medical radioisotope applications for the treatment of prostate, brain, …

Corey Williams — May 18, 2015, 10:44 AM EDT

Company Update (NYSE MKT:ISR): IsoRay, Inc.’s Cesium-131 Cancer Treatment Takes Center Stage at Weill Cornell’s International Symposium “Advances in Brachytherapy”

IsoRay, Inc. (NYSE MKT:ISR), a medical technology company and innovator in brachytherapy and medical isotope applications, announced that a number of industry leaders …

Corey Williams — May 11, 2015, 11:46 AM EDT

Company Update (NYSE MKT:ISR): Thomas Jefferson University Launches Head and Neck Cancer Study Utilizing Cesium-131 Where Current Treatments Have Failed

IsoRay, Inc. (NYSE MKT:ISR), a medical technology company and innovator in brachytherapy and medical isotope applications, announced the start of a new study …

Corey Williams — May 7, 2015, 12:55 PM EDT

Company Update (NYSE MKT:ISR): IsoRay, Inc. Cancer Fighting Isotope Cesium-131 Will Be Featured In Four Oral Presentations At The ABS Convention

IsoRay, Inc.(NYSEMKT:ISR), a medical technology company and innovator in seed brachytherapy and medical radioisotope applications, announced it will host a booth at the …

Corey Williams — April 9, 2015, 4:58 PM EDT

Company Update (NYSE MKT:ISR): Gynecologic Cancers Successfully Treated Using IsoRay’s Cesium-131 will be Presented by Dr. Jonathan Feddock Saturday Night

IsoRay Inc. (NYSE MKT: ISR) (www.

Corey Williams — March 24, 2015, 11:56 AM EDT

ISR: UPMC Study Reports Isoray’s Cesium-131 Prostate Treatment Provides Strong Cancer Control with Lower Side Effects.

Cesium-131 Seed Brachytherapy Offers Extremely High Efficacy Compared to Other Isotopes or Treatment Modalities Used in Treating Prostate Cancer, with the Advantage of …

Corey Williams — January 20, 2015, 10:37 AM EDT

Stock Update (NYSE:ISR): IsoRay’s Cesium-131 Therapy Takes Center Stage AT Russia’s Neftyanik Hospital a Center of Excellence Providing Cutting Edge Cancer Treatments

Leading Russian Cancer Specialists Dr. Zyryanov and Dr.

Corey Williams — January 13, 2015, 11:10 AM EDT

Stock Update (NYSE:ISR): IsoRay Ranked 5Th Highest Share Price Percentage Gainer (192%) in 2014 Among 2417 Companies Listed on the NYSE Group

IsoRay Ranked 5Th Highest Share Price Percentage Gainer (192%) In 2014 Richland, WA (January 12, 2015) – IsoRay Inc. (NYSE MKT: ISR), a …

Corey Williams — January 12, 2015, 9:51 AM EDT

Stay Ahead of Everyone Else

Get The Latest Stock News Alerts